172 related articles for article (PubMed ID: 2871096)
21. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
22. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
[No Abstract] [Full Text] [Related]
23. Methicillin-resistant Staphylococcus aureus.
Morris JG; Tenney JH
Ann Intern Med; 1983 Aug; 99(2):283-4. PubMed ID: 6881798
[No Abstract] [Full Text] [Related]
24. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
Kanno H
Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
[No Abstract] [Full Text] [Related]
25. Interaction between vancomycin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Guerriero JC
Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276
[TBL] [Abstract][Full Text] [Related]
26. [The control of methicillin-resistant Staphylococcus aureus; worthwhile?].
Vandenbroucke-Grauls CM; Verhoef J
Ned Tijdschr Geneeskd; 1990 Jun; 134(24):1163-5. PubMed ID: 2366903
[No Abstract] [Full Text] [Related]
27. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections: vancomycin update.
Gennery BA; Cooper GL
Br J Clin Pract Suppl; 1988 Feb; 57():100-1. PubMed ID: 3140867
[No Abstract] [Full Text] [Related]
29. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
Hiramatsu K; Hanaki H; Ino T; Yabuta K; Oguri T; Tenover FC
J Antimicrob Chemother; 1997 Jul; 40(1):135-6. PubMed ID: 9249217
[No Abstract] [Full Text] [Related]
30. Epidemiology and control of the 'modern' methicillin-resistant Staphylococcus aureus.
Casewell MW
J Hosp Infect; 1986 Mar; 7 Suppl A():1-11. PubMed ID: 2871090
[No Abstract] [Full Text] [Related]
31. Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.
Brown SM; Raflo GT; Fanning WL
Arch Ophthalmol; 2009 Jul; 127(7):941-2. PubMed ID: 19597122
[No Abstract] [Full Text] [Related]
32. [Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin].
Yourassowsky E; Schoutens E
Acta Clin Belg; 1971; 26(3):139-45. PubMed ID: 5211728
[No Abstract] [Full Text] [Related]
33. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
34. Update on emerging infections: news from the Centers for Disease Control and Prevention.
Moran GJ; Mount J
Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
[No Abstract] [Full Text] [Related]
35. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
Levine DP; Cushing RD; Jui J; Brown WJ
Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
Antony SJ
Scand J Infect Dis; 2006; 38(4):293-5. PubMed ID: 16718933
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Faville RJ; Zaske DE; Kaplan EL; Crossley K; Sabath LD; Quie PG
JAMA; 1978 Oct; 240(18):1963-5. PubMed ID: 249793
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Dworkin R; Modin G; Kunz S; Rich R; Zak O; Sande M
Antimicrob Agents Chemother; 1990 Jun; 34(6):1014-6. PubMed ID: 2393259
[TBL] [Abstract][Full Text] [Related]
40. The role of vancomycin in the treatment paradigm.
Stevens DL
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
